Skip to main content

Table 2 Clinical outcome

From: Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection

Groups Trial I Trial II
BV
EcoVag®
Group-1 BV EcoVag® Group-2 VVC EcoVag® Group-3 VVC
No EcoVag®
Patients enrolled 10 11 9 10
Patients lost to follow up 2 (no. 5 and 20)a 2 (no. 12, 19) 0 0
Patients analyzed 8 9 9 10
Patients cured at 6-months 4 (50 %) 6 (67 %) 9 (100 %) 10 (100 %)
Patients cured at 12-months 4 (50 %) 6 (67 %) 8 (89 %) 7 (70 %)
Relapses (identification number) 4 (no. 1, 2, 7, 8) 3 (no. 2, 4, 17) 0 3 (no. 23, 25, 28)
Patients with new sexual partner on follow up 2 (no. 2, 7)b 3 (no. 2, 4, 17) 1 (no. 7) 0
New sexual partner before relapses of BV 2 (no. 2, 7) 3 (no. 2, 4, 17) 0 0
Chlamydia infection 0 1 (no. 4) 0 0
Surgical abortion and post-operative infection 0 1 (no. 17) 0 0
Both BV and VVC 0 1 (no. 15)c 0 0
  1. aNumber of patients and identification number in parenthesis
  2. bData not available for one woman (no. 1)
  3. cThe patient got cured of BV